BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 34035532)

  • 1. A patent waiver on COVID vaccines is right and fair.
    Nature; 2021 May; 593(7860):478. PubMed ID: 34035532
    [No Abstract]   [Full Text] [Related]  

  • 2. It's time to consider a patent reprieve for COVID vaccines.
    Nature; 2021 Apr; 592(7852):7. PubMed ID: 33785920
    [No Abstract]   [Full Text] [Related]  

  • 3. Omicron is bad but the global response is worse.
    Nature; 2021 Dec; 600(7888):190. PubMed ID: 34876667
    [No Abstract]   [Full Text] [Related]  

  • 4. Time is running out for COVID vaccine patent waivers.
    Nature; 2022 Mar; 603(7903):764. PubMed ID: 35352056
    [No Abstract]   [Full Text] [Related]  

  • 5. Pool patents to get COVID vaccines and drugs to all.
    Billette de Villemeur E; Dequiedt V; Versaevel B
    Nature; 2021 Mar; 591(7851):529. PubMed ID: 33742180
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges in the rollout of COVID-19 vaccines worldwide.
    Burki TK
    Lancet Respir Med; 2021 Apr; 9(4):e42-e43. PubMed ID: 33684355
    [No Abstract]   [Full Text] [Related]  

  • 7. To curb COVID-19, global health must go local.
    Nat Med; 2021 Jun; 27(6):929. PubMed ID: 34031608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free licensing of vaccines to end the COVID-19 crisis.
    Bozorgmehr K; Jahn R; Stuckler D; McKee M
    Lancet; 2021 Apr; 397(10281):1261-1262. PubMed ID: 33743843
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: save lives with open intellectual-property licences.
    Contreras JL; Eisen M; Peters DM
    Nature; 2020 Jul; 583(7818):683. PubMed ID: 32724145
    [No Abstract]   [Full Text] [Related]  

  • 10. Access considerations for a COVID-19 vaccine for South Africa.
    Bangalee V; Suleman F
    S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and covid-19 in South Africa.
    Freer J; Mudaly V
    BMJ; 2022 Jan; 376():e069807. PubMed ID: 35086921
    [No Abstract]   [Full Text] [Related]  

  • 12. Why a pioneering plan to distribute COVID vaccines equitably must succeed.
    Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047
    [No Abstract]   [Full Text] [Related]  

  • 13. The COVID vaccine challenges that lie ahead.
    Nature; 2020 Nov; 587(7835):522. PubMed ID: 33235368
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID vaccines to reach poorest countries in 2023 - despite recent pledges.
    Padma TV
    Nature; 2021 Jul; 595(7867):342-343. PubMed ID: 34226742
    [No Abstract]   [Full Text] [Related]  

  • 15. Key steps in our journey to a COVID-19 vaccine program.
    Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
    Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
    [No Abstract]   [Full Text] [Related]  

  • 16. Chelsea Clinton urges global sharing of COVID vaccine technology.
    Maxmen A
    Nature; 2021 Aug; 596(7872):331. PubMed ID: 34376853
    [No Abstract]   [Full Text] [Related]  

  • 17. Why did the world's pandemic warning system fail when COVID hit?
    Maxmen A
    Nature; 2021 Jan; 589(7843):499-500. PubMed ID: 33500574
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 in the Caribbean.
    Burki TK
    Lancet Respir Med; 2021 Apr; 9(4):e46. PubMed ID: 33581745
    [No Abstract]   [Full Text] [Related]  

  • 19. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New WTO leader faces COVID-19 challenges.
    Zarocostas J
    Lancet; 2021 Feb; 397(10276):782. PubMed ID: 33640051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.